论文信息 - Cediranib in patients with malignant mesothelioma: a phase II trial of the University of Chicago Phase II Consortium. - 字舞流文

Cediranib in patients with malignant mesothelioma: a phase II trial of the University of Chicago Phase II Consortium.

D. Gandara | E. Vokes | W. Stadler | M. Vincent | N. Leighl | H. Kindler | B. Gitlitz | M. Koczywas | R. Kunnavakkam | E. Agamah | Nicholas P. Campbell | Sachdev Thomas | N. P. Campbell